Gürler F - Search Results

1

Does docetaxel matter in metastatic gastric cancer? FOLFOX versus FLOT regimens as first-line treatment.

Gürler F, İlhan A, Güven DC, Turhan O, Kurt İnci B, Sütçüoğlu O, Yildiz F, Arik Z, Öksüzoğlu B, Yalçin Ş, Özdemir N, Yazici O, Özet A. Gürler F, et al. Anticancer Drugs. 2022 Jan 1;33(1):e477-e485. doi: 10.1097/CAD.0000000000001143. Anticancer Drugs. 2022. PMID: 34261917

2

"How long does crizotinib work? a rare case of recurrent inflammatory myofibroblastic tumor".

Albayrak HC, Gürler F, Sütçüoğlu O, Akyürek N, Özet A. Albayrak HC, et al. Among authors: gurler f. Anticancer Drugs. 2022 Jan 1;33(1):109-111. doi: 10.1097/CAD.0000000000001137. Anticancer Drugs. 2022. PMID: 34261914

3

Effect of serum uric acid level and Multinational Association for Supportive Care in Cancer risk score on febrile neutropenia mortality.

Sütcüoğlu O, Akdoğan O, İnci BK, Gürler F, Özdemir N, Yazıcı O. Sütcüoğlu O, et al. Among authors: gurler f. Support Care Cancer. 2021 Feb;29(2):1047-1053. doi: 10.1007/s00520-020-05587-7. Epub 2020 Jun 25. Support Care Cancer. 2021. PMID: 32583058

4

The role of serum albumin/globulin ratio in combination with prognostic risk indexes of febrile neutropenia.

Sütcüoğlu O, Akdoğan O, Gürler F, Kurt İnci B, Özdemir N, Özet A, Yazıcı O. Sütcüoğlu O, et al. Among authors: gurler f. Int J Clin Pract. 2021 Jul;75(7):e14185. doi: 10.1111/ijcp.14185. Epub 2021 Apr 5. Int J Clin Pract. 2021. PMID: 33783936

5

Brigatinib-induced tuberculosis reactivation: A case report.

Keş V, Sütcüoğlu O, Gürler F, Yazıcı O, Özet A. Keş V, et al. Among authors: gurler f. Curr Probl Cancer. 2021 Dec;45(6):100738. doi: 10.1016/j.currproblcancer.2021.100738. Epub 2021 Apr 10. Curr Probl Cancer. 2021. PMID: 33867154

6

Current status of biosimilars in Turkey: A survey among medical oncologists.

Gürler F, Kasım DD, Kurt İnci B, Sütçüoğlu O, Ünsal O, Aslan V, Tahtacı G, Özdemir N, Üner A, Günel N, Özet A, Yazıcı O. Gürler F, et al. J Oncol Pharm Pract. 2022 Oct;28(7):1516-1523. doi: 10.1177/10781552211031643. Epub 2021 Jul 27. J Oncol Pharm Pract. 2022. PMID: 34313505

7

A Case of Myasthenia Gravis with Two Primary Tumors: Paraneoplastic or Incidental?

Uğur T, Gürler F, Cengiz B, Kuruoğlu R, Özet A. Uğur T, et al. Among authors: gurler f. J Gastrointest Cancer. 2022 Sep;53(3):837-840. doi: 10.1007/s12029-021-00702-1. Epub 2021 Aug 31. J Gastrointest Cancer. 2022. PMID: 34463912 No abstract available.

8

Sinonasal SMARCB1 (INI1) Deficient Carcinoma with Yolk Sac Tumor Differentiation: A Case Report and Treatment Options.

Hazir B, Şímșek B, Erdemír A, Gürler F, Yazici O, Kizil Y, Aydíl U. Hazir B, et al. Among authors: gurler f. Head Neck Pathol. 2022 Jun;16(2):596-601. doi: 10.1007/s12105-021-01375-9. Epub 2021 Aug 21. Head Neck Pathol. 2022. PMID: 34420180 Free PMC article. Review.

9

A prognostic parameter in advanced non-small cell lung cancer: the ratio of hemoglobin-to-red cell distribution width.

Bozkaya Y, Kurt B, Gürler F. Bozkaya Y, et al. Among authors: gurler f. Int J Clin Oncol. 2019 Jul;24(7):798-806. doi: 10.1007/s10147-019-01417-x. Epub 2019 Feb 19. Int J Clin Oncol. 2019. PMID: 30783810

10

The prognostic value of tumor/lymph node standardized uptake value max ratio and correlation with hematologic parameters in stage III nonsmall cell lung cancer.

Açikgoz Y, Gurler F, Inci BK, Ergun Y, Ucar G, Dirikoc M, Esen SA, Tekin BO, Bal O, Dogan M, Uncu D. Açikgoz Y, et al. Among authors: gurler f. Medicine (Baltimore). 2020 Nov 25;99(48):e23168. doi: 10.1097/MD.0000000000023168. Medicine (Baltimore). 2020. PMID: 33235077 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

26 results

Search Page

Filters